S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

Adient Stock Price, News & Analysis (NYSE:ADNT)

$32.47
+0.30 (+0.93%)
(As of 11/29/2023 ET)
Compare
Today's Range
$32.32
$33.18
50-Day Range
$30.20
$37.10
52-Week Range
$30.10
$47.50
Volume
1.52 million shs
Average Volume
861,225 shs
Market Capitalization
$3.04 billion
P/E Ratio
15.03
Dividend Yield
N/A
Price Target
$46.25

Adient MarketRank™ Stock Analysis

Analyst Rating
Hold
2.22 Rating Score
Upside/​Downside
42.4% Upside
$46.25 Price Target
Short Interest
Healthy
3.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
-6.09
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
46.25%
From $3.07 to $4.49 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Auto/Tires/Trucks Sector

36th out of 91 stocks

Motor Vehicle Parts & Accessories Industry

16th out of 36 stocks


ADNT stock logo

About Adient Stock (NYSE:ADNT)

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers. It serves automotive original equipment manufacturers in North America and South America; Europe, Middle East, and Africa; and the Asia Pacific/China. Adient plc was incorporated in 2016 and is based in Dublin, Ireland.

ADNT Stock Price History

ADNT Stock News Headlines

Adient (NYSE:ADNT) Rating Lowered to Hold at StockNews.com
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Where Adient Stands With Analysts
Adient plc (NYSE:ADNT) Q4 2023 Earnings Call Transcript
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Adient Q3 Results Miss Estimates; Guides FY24 Below View
Should Value Investors Buy Adient (ADNT) Stock?
Wells Fargo Reaffirms Their Buy Rating on Adient (ADNT)
Adient: Too Early To Turn Bullish
Here's Why Adient (ADNT) is a Strong Momentum Stock
See More Headlines
Receive ADNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adient and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
11/29/2023
Next Earnings (Estimated)
2/06/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Motor vehicle parts & accessories
Sub-Industry
N/A
Fax
N/A
Employees
70,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$46.25
High Stock Price Target
$62.00
Low Stock Price Target
$35.00
Potential Upside/Downside
+42.4%
Consensus Rating
Hold
Rating Score (0-4)
2.22
Research Coverage
9 Analysts

Profitability

Net Income
$205 million
Pretax Margin
1.92%

Debt

Sales & Book Value

Annual Sales
$15.40 billion
Cash Flow
$5.88 per share
Book Value
$27.17 per share

Miscellaneous

Free Float
92,667,000
Market Cap
$3.04 billion
Optionable
Optionable
Beta
2.77
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report














ADNT Stock Analysis - Frequently Asked Questions

Should I buy or sell Adient stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Adient in the last twelve months. There are currently 2 sell ratings, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ADNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ADNT, but not buy additional shares or sell existing shares.
View ADNT analyst ratings
or view top-rated stocks.

What is Adient's stock price target for 2024?

9 analysts have issued 1-year price targets for Adient's shares. Their ADNT share price targets range from $35.00 to $62.00. On average, they predict the company's share price to reach $46.25 in the next twelve months. This suggests a possible upside of 42.4% from the stock's current price.
View analysts price targets for ADNT
or view top-rated stocks among Wall Street analysts.

How have ADNT shares performed in 2023?

Adient's stock was trading at $34.69 at the start of the year. Since then, ADNT stock has decreased by 6.4% and is now trading at $32.47.
View the best growth stocks for 2023 here
.

Are investors shorting Adient?

Adient saw a drop in short interest in November. As of November 15th, there was short interest totaling 3,120,000 shares, a drop of 8.0% from the October 31st total of 3,390,000 shares. Based on an average daily trading volume, of 839,500 shares, the short-interest ratio is currently 3.7 days. Currently, 3.4% of the shares of the company are short sold.
View Adient's Short Interest
.

When is Adient's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 6th 2024.
View our ADNT earnings forecast
.

How were Adient's earnings last quarter?

Adient plc (NYSE:ADNT) posted its quarterly earnings data on Wednesday, November, 8th. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.52 by $0.01. The business earned $3.70 billion during the quarter, compared to analysts' expectations of $3.78 billion. Adient had a trailing twelve-month return on equity of 8.14% and a net margin of 1.33%. Adient's quarterly revenue was up 1.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.53 earnings per share.

What is Douglas G. DelGrosso's approval rating as Adient's CEO?

100 employees have rated Adient Chief Executive Officer Douglas G. DelGrosso on Glassdoor.com. Douglas G. DelGrosso has an approval rating of 77% among the company's employees.

What other stocks do shareholders of Adient own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adient investors own include Johnson Controls International (JCI), AT&T (T), Exxon Mobil (XOM), Cisco Systems (CSCO), AbbVie (ABBV), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Ford Motor (F) and Johnson & Johnson (JNJ).

Who are Adient's major shareholders?

Adient's stock is owned by many different retail and institutional investors. Top institutional shareholders include FMR LLC (14.83%), Pzena Investment Management LLC (1.63%), Entrust Global Partners L L C (1.55%), Northern Trust Corp (1.40%), Bank of New York Mellon Corp (1.03%) and JPMorgan Chase & Co. (0.92%). Insiders that own company stock include Douglas G Delgrosso, Gregory Scott Smith, Heather M Tiltmann, James Conklin, Jeffrey Stafeil, Jerome J Dorlack, Michel Pierre Rose Berthelin and Peter Carlin.
View institutional ownership trends
.

How do I buy shares of Adient?

Shares of ADNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:ADNT) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -